Skip to main content

Connor, Clark & Lunn Investment Management Ltd.

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1596800 VANCOUVER, A1

Position in KNSA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$36,617,642
+$5,338,006 QoQ
Shares Held
572,598
-11.9% QoQ
Ownership
0.367%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#21
of 264 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $83,482,045 across 14 Drug Manufacturers - Specialty & Generic names. KNSA ranks #1 (43.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 KNSA
Kiniksa Pharmaceuticals International, plc
This page
572,598 $36,617,642

All Filings in KNSA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $36,617,642 572,598
2026-03-31 $31,279,636 649,629
2025-12-31 $30,497,197 739,326
2025-09-30 $28,165,534 725,355
2025-06-30 $17,257,474 623,689
2025-03-31 $8,878,292 399,743
2024-12-31 $6,071,391 306,946
2024-09-30 $8,098,359 324,064
2024-06-30 $4,314,244 231,079